NeuroSys is both a CRO and a drug discovery company focused on neurodegenerative diseases.
NeuroSys is both a CRO and a drug discovery company focused on neurodegenerative diseases.
CMDBioscience is a computational biotech company using computational methods to enable transformational peptide drug discovery.
PamGene is a biotech company specialized in kinase and nuclear receptor assays for personalized medicine and drug discovery.
BioTek is a global leader in developing and manufacturing microplate instrumentations and software to facilitate drug discovery process and life science research.
Selvita is a biotech company offering drug discovery support at every step of the process, from the early discovery phase up to preclinical research. Selvita delivers a comprehensive panel of solutions to accelerate and decrease the cost of the introduction of new drugs to the market.
Antisense Therapeutics is a biopharma drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics.
Cancer Research Technology is a biotech company specialized in the field of cancer research and development, including 30 years’ specialist experience in the commercialization of cancer research tools.
Zenith Epigenetics is a biotech company developing bromodomain (BET) inhibitors for the treatment of cancer and autoimmune disorders. Zenith Epigenetics aims to become a leading epigenetic company translating bromodomain biology into impactful therapies.
Somalogic is biotech company using its proprietary Slow Off-rate Modified Aptamer (“SOMAmer”) technology along with its unbiased biomarker discovery assay (SOMAscan) to develop new proteomics tools.
Horizon Discovery is a trusted supplier of genetically-defined cell lines, genomic reference standards, reporter gene assay kits and contract research services. Horizon Discovery already supports lots of organizations engaged in drug discovery and development, bio-pharmaceutical process optimization and clinical diagnostic development.